Prognostic factors for response and survival of second-line chemotherapy in patients with relapsed small cell lung cancer (SCLC)

被引：0
|
作者：
Kim, Y. [1 ]
Goto, K. [1 ]
Yoh, K. [1 ]
Niho, S. [1 ]
Ohmatsu, H. [1 ]
Kubota, K. [1 ]
Saijo, N. [1 ]
Nishiwaki, Y. [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
18023
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Second-line chemotherapy for small-Cell Lung Cancer (SCLC)
    Kim, Young Hak
    Mishima, Michiaki
    CANCER TREATMENT REVIEWS, 2011, 37 (02) : 143 - 150
  • [2] Second-line chemotherapy for relapsed small cell lung cancer
    Ebi, N
    Kubota, K
    Nishiwaki, Y
    Hojo, F
    Matsumoto, T
    Kakinuma, R
    Ohmatsu, H
    Sekine, I
    Yokosaki, M
    Gotoh, K
    Yamamoto, H
    Kodama, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 166 - 169
  • [3] Outcomes of second-line chemotherapy in patients with relapsed extensive small cell lung cancer
    Froeschl, Sandra
    Nicholas, Garth
    Gallant, Victor
    Laurie, Scott A.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) : 163 - 169
  • [4] Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer
    Wakuda, Kazushige
    Miyawaki, Taichi
    Miyawaki, Eriko
    Mamesaya, Nobuaki
    Kawamura, Takahisa
    Kobayashi, Haruki
    Omori, Shota
    Nakashima, Kazuhisa
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Mori, Keita
    Endo, Masahiro
    Takahashi, Toshiaki
    IN VIVO, 2019, 33 (06): : 2229 - 2234
  • [5] Survival and prognostic factors in elderly patients receiving second-line chemotherapy for relapsed small-cell lung cancer: Results from the Japanese Joint Committee of Lung Cancer Registry
    Igawa, Satoshi
    Naoki, Katsuhiko
    Shintani, Yasushi
    Sekine, Ikuo
    Shukuya, Takehito
    Takayama, Koichi
    Inoue, Akira
    Okamoto, Isamu
    Kiura, Katsuyuki
    Takahashi, Kazuhisa
    Yamamoto, Nobuyuki
    Takiguchi, Yuichi
    Miyaoka, Etsuo
    Okumura, Meinoshin
    Yoshino, Ichiro
    LUNG CANCER, 2020, 146 : 160 - 164
  • [6] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Lovly, Christine Marie
    Li, Chung-I
    Hutchison, Anne Smith
    Carbone, David Paul
    Johnson, David H.
    Keedy, Vicki Leigh
    Pao, William
    Sandler, Alan
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Venepalli, N. K.
    Hutchison, A. S.
    Carbone, D. P.
    Johnson, D. H.
    Keedy, V. L.
    Pao, W.
    Sandler, A.
    Horn, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients
    Schmittel, Alexander
    Knoedler, Maren
    Hortig, Patricia
    Schulze, Karsten
    Thiel, Eckhard
    Keilholz, Ulrich
    LUNG CANCER, 2007, 55 (01) : 109 - 113
  • [9] Utility of second-line chemotherapy for relapsed extensive small cell lung cancer (E-SCLC) in clinical practice: Who benefits?
    Froeschl, S
    Laurie, S
    Gallant, V
    LUNG CANCER, 2005, 49 : S318 - S319
  • [10] OUTCOMES OF SMALL CELL LUNG CANCER (SCLC) PATIENTS TREATED WITH SECOND-LINE CHEMOTHERAPY (SL): A RETROSPECTIVE ANALYSIS OF 166 PATIENTS
    Garassino, M. C.
    Califano, R.
    Michetti, G.
    Borgonovo, K.
    Lo Dico, M.
    Fatigoni, S.
    Martelli, O.
    Ghidini, A.
    Bareggi, C.
    Torri, V.
    LUNG CANCER, 2009, 64 : S62 - S62
12345